South Florida

Integrated Kidney Partners II LLC

Primary Contact

 

Ryan Pardo
Ryan.Pardo@usrenalcare.com

 

KCE Participants

 

Dialysis Facilities

5072020, LLC 70820 VENTURES, LLC
USRC UPTOWN NAPLES LLC 71120 VENTURES, LLC
71020 VENTURES, LLC  70920 VENTURES, LLC
70620 PARTNERS, LLC  70720 PARTNERS, LLC
USRC MUSTANG DIALYSIS, LLC NEW SMYRNA BEACH ARTIFICIAL KIDNEY, LC

 

Practices

 

ASSOCIATES IN NEPHROLOGY BUTCHER & DEVACAANTHAN MD PA

AASTHA PARSA PEGGY DEPALMA
NICOLE WILCOX MARY MOURACADE
KATIE ANDERSON TAMIM GHITH
BASUDEV PUDASAINI NEETU MALHOTRA
BISHAL RAWAL ROBERT LIBBEY
EVAN GROSS ROBERT PAYNE
JOEL VANSICKLER  SOURAB DHUNGEL
JOHN CONREY SYEDA KHAN
MAGDALA GUERRIER

MOGILISHETTY PLLC

ANDREW NOWAKOWSKI BEENU SINGH
GAUTHAM MOGILISHETTY IBRAHIM KHAMBATI
MELONEY OLIVEIRA

 

Independent Practitioner

CHRISTOPHER MAI

 

Preferred Providers

Practice
PERSONAL RECOVERY NETWORK LLC

 

Joint Ventures

There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.

 

Administrative Lead

Name Employer
Alan St. Pierre U.S. Renal Care

Clinical Lead

Name Employer
Bishal Rawal Associates in Nephrology

KCE Governing Body Members

Name Employer
Alan St. Pierre U.S. Renal Care
Bishal Rawal Associates in Nephrology
Basudev Pudasaini Associates in Nephrology
Natasha Dave Associates in Nephrology`
Carol Ecklund U.S. Renal Care
Gautham Mogilishetty Mogilishetty PLLC
Lori Hartwell Consumer Advocate
Stephen Busenlehner U.S. Renal Care

Shared Savings and Shared Losses Information

 

a. Gross Savings/Losses BEFORE CMS withholds:

PY2022: $1,598,972

 

b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation;

PY2022: ($71,294)

 

c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and

PY2022: N/A

 

d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers

PY2022: N/A

 

d. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.

PY2022 TQS: 25%*

*Devastation from Hurricane Ian prevented performance on Quality measures. CMS did not provide relief on Quality performance via Extreme and Unexpected Circumstances.

 

e. Total Ancillary Income*

PY2022: $706,889

*Includes (1) 100% of Installment 1 2022 Kidney Transplant Bonus (KTB) (2) 100% of post-sequestration home dialysis bonus and (3) 100% of post-sequestration capitation payments deposited quarterly